JP2007530420A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007530420A5 JP2007530420A5 JP2006518870A JP2006518870A JP2007530420A5 JP 2007530420 A5 JP2007530420 A5 JP 2007530420A5 JP 2006518870 A JP2006518870 A JP 2006518870A JP 2006518870 A JP2006518870 A JP 2006518870A JP 2007530420 A5 JP2007530420 A5 JP 2007530420A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fugetactic
- composition according
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48555003P | 2003-07-07 | 2003-07-07 | |
| PCT/US2004/021725 WO2005009350A2 (en) | 2003-07-07 | 2004-07-07 | Fugetactic proteins, compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007530420A JP2007530420A (ja) | 2007-11-01 |
| JP2007530420A5 true JP2007530420A5 (enExample) | 2008-03-06 |
Family
ID=34102663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006518870A Abandoned JP2007530420A (ja) | 2003-07-07 | 2004-07-07 | ｆｕｇｅｔａｃｔｉｃタンパク質、組成物および使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7745578B2 (enExample) |
| EP (1) | EP1648387A2 (enExample) |
| JP (1) | JP2007530420A (enExample) |
| CA (1) | CA2532035A1 (enExample) |
| WO (1) | WO2005009350A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008127355A2 (en) * | 2006-10-06 | 2008-10-23 | Celtaxsys, Inc. | Chemorepulsion of cells |
| CN104678106B (zh) | 2008-08-18 | 2016-12-07 | 中胚有限公司 | 单克隆抗体stro-4 |
| EP2346525A4 (en) * | 2008-10-02 | 2012-05-09 | Celtaxsys Inc | METHODS OF MODULATION OF NEGATIVE CHIMOTAXIA OF IMMUNE CELLS |
| US9775816B2 (en) | 2013-11-07 | 2017-10-03 | The General Hospital Corporation | Eluting matrix and uses thereof |
| BR102014002362A8 (pt) | 2014-01-30 | 2018-04-17 | Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs | método de imunomodulação e/ou preservação de órgãos ex-vivo, composições, processo e usos |
| HK1259026A1 (zh) * | 2015-09-18 | 2019-11-22 | 综合医院公司以麻省总医院名义经营 | 用於治疗癌症的抗趋除剂的局部递送 |
| WO2017049237A1 (en) * | 2015-09-18 | 2017-03-23 | The General Hospital Corporation Dba Massachusetts General Hospital | Personalized approach to dosage of anti-fugetactic agent for treatment of cancer |
| US20200215110A1 (en) * | 2016-09-09 | 2020-07-09 | The General Hospital Corporation | Ex vivo antigen-presenting cells or activated cd-positive t cells for treatment of infectious diseases |
| WO2019035919A1 (en) * | 2017-08-16 | 2019-02-21 | University Of Maryland, Baltimore | COMPOSITIONS AND METHODS FOR INHIBITING L-PLASTINE ACTIVITY IN OSTEOCLASTES TO REDUCE BONE LOSS |
| CN111197057B (zh) * | 2018-11-19 | 2024-04-19 | 中国科学院分子细胞科学卓越创新中心 | 调控免疫细胞迁移的组合物和方法 |
| CN117843757B (zh) * | 2024-01-08 | 2024-09-06 | 四川省畜牧总站 | 一种抗氧化抗冻蛋白及其在羊冷冻精液稀释液中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5360715A (en) * | 1988-06-07 | 1994-11-01 | California Institute Of Technology | Plastin isoforms and their uses |
| US5750119A (en) * | 1994-01-13 | 1998-05-12 | Mount Sinai School Of Medicine Of The City University Of New York | Immunotherapeutic stress protein-peptide complexes against cancer |
| US6362934B1 (en) * | 1999-03-24 | 2002-03-26 | Storage Technology Corporation | Highly aligned thin film tape head and method of making same |
| US20030104622A1 (en) * | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
| EP1218030A4 (en) * | 1999-09-10 | 2004-09-15 | Univ Fordham | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRANSPLANT REJECTION BY USING HEAT SHOCK PROTEINS |
| US20010034042A1 (en) * | 2000-01-20 | 2001-10-25 | Srivastava Pramod K. | Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| US6812205B2 (en) * | 2000-03-15 | 2004-11-02 | The Brigham & Women's Hospital, Inc. | Suppression of vascular disorders by mucosal administration of heat shock protein peptides |
| AU2001253140A1 (en) * | 2000-04-03 | 2001-10-15 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Tumor markers in ovarian cancer |
| EP1423080A4 (en) * | 2001-03-01 | 2009-06-03 | Conforma Therapeutics Corp | PROCESS FOR TREATING PROLIFERATIVE GENETIC DISORDERS WITH HSP90 INHIBITORS |
-
2004
- 2004-07-07 CA CA002532035A patent/CA2532035A1/en not_active Abandoned
- 2004-07-07 EP EP04786046A patent/EP1648387A2/en not_active Withdrawn
- 2004-07-07 WO PCT/US2004/021725 patent/WO2005009350A2/en not_active Ceased
- 2004-07-07 US US10/563,726 patent/US7745578B2/en not_active Expired - Fee Related
- 2004-07-07 JP JP2006518870A patent/JP2007530420A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5680661B2 (ja) | Ｉｌ−２に由来する免疫調節ポリペプチド並びに癌及び慢性感染症の治療におけるその使用 | |
| JP3763479B2 (ja) | 生物学的に活性なＴＧＦ−β１およびＴＧＦ−β２ペプチド | |
| JP6712993B2 (ja) | 免疫細胞を惹起及び／又は活性化するための免疫応答刺激性サイトカインを発現する遺伝子改変型間葉系幹細胞 | |
| KR102113809B1 (ko) | 조직 재생을 유도하기 위한 펩티드 및 그의 이용 | |
| CA2360106C (en) | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies | |
| US20050142138A1 (en) | Endothelial cell expression patterns | |
| JPH04507195A (ja) | 腫瘍壊死因子結合リガンド | |
| EA003675B1 (ru) | Белки, связывающие интерлейкин-18, их получение и применение | |
| Movila et al. | Macrophage migration inhibitory factor (MIF) supports homing of osteoclast precursors to peripheral osteolytic lesions | |
| KR970707141A (ko) | 종양 괴사 인자-감마(Tumor necrosis factor-gamma) | |
| CN110935025A (zh) | 用于治疗和/或预防自身免疫性疾病和用于形成调节t细胞的试剂 | |
| JP2001518304A (ja) | アンギオスタチン成分を含む融合タンパク質及び抗腫瘍療法におけるその使用 | |
| JPH06504440A (ja) | 関節炎治療用切形インターロイキン−１受容体遺伝子 | |
| ES2436427T3 (es) | Péptido sintético que se enlaza con CD154 humano y usos del mismo | |
| CN118240093A (zh) | 一种靶向her2与egfr的三特异性t细胞衔接器及其应用 | |
| RU2398776C2 (ru) | Тимус-специфический белок | |
| KR101118481B1 (ko) | 항-ｔｎｆ 처리와 병용된 체외 광분리반출법 | |
| AU765126B2 (en) | Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer | |
| CA2131623A1 (en) | Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides | |
| CN102898508B (zh) | 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途 | |
| JP4275065B2 (ja) | キメラ拮抗物質ａｎｔｈ１ | |
| RU2446174C2 (ru) | Пептид с антипролиферативной активностью и фармацевтическая композиция для лечения пролиферативных заболеваний | |
| EP0333517A2 (en) | Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor | |
| Li et al. | A nanosystem targeting tissue inhibitor of metalloproteinase-1 for continuous spatiotemporal idiopathic pulmonary fibrosis therapy | |
| WO2000015175A2 (en) | Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells |